Target intelligence / Profile preview

Voltage-dependent L-type calcium channel subunit alpha-1F

Molecular classification
Ion channel, Voltage-gated calcium channel, High voltage-activated (HVA) calcium channel
01

Overview

The voltage-dependent L-type calcium channel subunit alpha-1F is the pore-forming alpha-1 subunit of the Cav1.4 channel encoded by the CACNA1F gene[4][1]. It is predominantly expressed in the retina within photoreceptor synaptic terminals, where it plays a crucial role in visual signal transmission by mediating sustained calcium influx in response to membrane depolarization[4]. As part of the high voltage-activated (HVA) L-type calcium channel family, alpha-1F forms heteromultimeric complexes with auxiliary subunits (alpha-2/delta, beta, and sometimes gamma)[1][3]. The alpha-1F subunit is essential for enabling calcium-dependent processes linked to neurotransmitter release, with distinct features compared to other L-type channel isoforms (such as Cav1.2 and Cav1.3). Mutations in CACNA1F cause congenital stationary night blindness type 2A (CSNB2A) and other X-linked visual disorders[4]. L-type channels, including alpha-1F, are generally sensitive to dihydropyridine calcium antagonists, though alpha-1F selectivity is limited among current drugs[4][1]. Broader L-type channel inhibition affects muscle, endocrine, and neuronal function, contributing to safety concerns for systemic therapies.

Other names
Cav1.4CACNA1FL-type calcium channel alpha-1F subunitL-type voltage-dependent calcium channel subunit alpha-1F
02

Mechanism of action

Blockade of L-type calcium channels, inhibiting calcium influx and reducing downstream calcium-dependent signaling (for drugs in the L-type blocker class) Modulation of neurotransmitter/hormone release, muscle contraction, and gene expression via alteration of membrane calcium entry

03

Biological functions

Calcium ion transportDetection of light stimulus involved in visual perceptionSignal transduction in neurons and sensory cellsRegulation of gene expression via calcium influxParticipation in cell death and cell motility processes
04

Disease associations

Retinal diseases (notably congenital stationary night blindness type 2A, CSNB2A)Visual disorders (complete and incomplete X-linked congenital stationary night blindness)Neurodegenerative diseases (potentially, through calcium dysregulation)Other (rarely, roles in other tissues cannot be excluded but are less established)
05

Safety considerations

Off-target effects due to broad expression of L-type calcium channels in cardiovascular and nervous systems (risk with non-selective blockers)Disturbance of calcium homeostasis in neurons or muscle cells may cause unintended physiological effects including bradycardia, hypotension, or central nervous system depression, especially if less-specific L-type channel blockers are used
06

Interacting drugs

Dihydropyridines (e.g., nifedipine, amlodipine; L-type channel blockers—general group, not selective for alpha-1F)

1 more in the full profile.

07

Biomarkers

Mutational screening of CACNA1F for diagnosis of congenital stationary night blindness and related retinal diseases (primarily for identifying affected individuals or families)

Beyond the preview

Go deeper on Voltage-dependent L-type calcium channel subunit alpha-1F.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-dependent L-type calcium channel subunit alpha-1F.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call